MaxCyte shares trading for last time in London

(Sharecast News) - MaxCyte confirmed on Wednesday that trading of its shares on London's AIM market would cease at the close of trading, with the cancellation of its AIM listing taking effect at 0700 BST on Thursday. It said the decision followed shareholder approval at the company's annual general meeting on 18 June.

The cell engineering company, which provides platform technologies for the development of next-generation cell therapeutics, said it would retain its listing on the Nasdaq Global Select Market in the United States, where its shares would continue to trade under the ticker MXCT.

MaxCyte noted that following the delisting, there would no longer be a public market in the UK for its common stock.

At 1149 BST, shares in MaxCyte were down 5.94% in London, at 150.5p.

Reporting by Josh White for Sharecast.com.